NDLI: A proof-of-concept study on bioorthogonal-based pretargeting and signal amplify radiotheranostic strategy

Content Provider	Springer Nature : BioMed Central
Author	Yang, Hongzhang Zeng, Xinying Liu, Jia Li, Jingchao Li, Yun Zhang, Qinglin Shu, Linlin Liu, Huanhuan Wang, Xueqi Liang, Yuanyuan Hu, Ji Huang, Lumei Guo, Zhide Zhang, Xianzhong
Abstract	Background Radiotheranostics differs from the vast majority of other cancer therapies in its capacity for simultaneous imaging and therapy, and it is becoming more widely implemented. A balance between diagnostic and treatment requirements is essential for achieving effective radiotheranostics. Herein, we propose a proof-of-concept strategy aiming to address the profound differences in the specific requirements of the diagnosis and treatment of radiotheranostics. Results To validate the concept, we designed an s-tetrazine (Tz) conjugated prostate-specific membrane antigen (PSMA) ligand (DOTA-PSMA-Tz) for 68Ga or 177Lu radiolabeling and tumor radiotheranostics, a trans-cyclooctene (TCO) modified Pd@Au nanoplates (Pd@Au-PEG-TCO) for signal amplification, respectively. We then demonstrated this radiotheranostic strategy in the tumor-bearing mice with the following three-step procedures: (1) i.v. injection of the [68Ga]Ga-PSMA-Tz for diagnosis; (2) i.v. injection of the signal amplification module Pd@Au-PEG-TCO; (3) i.v. injection of the [177Lu]Lu-PSMA-Tz for therapy. Firstly, this strategy was demonstrated in 22Rv1 tumor-bearing mice via positron emission tomography (PET) imaging with [68Ga]Ga-PSMA-Tz. We observed significantly higher tumor uptake (11.5 ± 0.8%ID/g) with the injection of Pd@Au-PEG-TCO than with the injection [68Ga]Ga-PSMA-Tz alone (5.5 ± 0.9%ID/g). Furthermore, we validated this strategy through biodistribution studies of [177Lu]Lu-PSMA-Tz, with the injection of the signal amplification module, approximately five-fold higher tumor uptake of [177Lu]Lu-PSMA-Tz (24.33 ± 2.53% ID/g) was obtained when compared to [177Lu]Lu-PSMA-Tz alone (5.19 ± 0.26%ID/g) at 48 h post-injection. Conclusion In summary, the proposed strategy has the potential to expand the toolbox of pretargeted radiotherapy in the field of theranostics. Graphical Abstract
Related Links	https://jnanobiotechnology.biomedcentral.com/counter/pdf/10.1186/s12951-024-02312-y.pdf
Ending Page	12
Page Count	12
Starting Page	1
File Format	HTM / HTML
ISSN	14773155
DOI	10.1186/s12951-024-02312-y
Journal	Journal of Nanobiotechnology
Issue Number	1
Volume Number	22
Language	English
Publisher	BioMed Central
Publisher Date	2024-03-10
Access Restriction	Open
Subject Keyword	Biotechnology Nanotechnology Molecular Medicine Radiotheranostics Click-mediated bioorthogonal chemistry Tumor signal amplification Pretargeting PSMA
Content Type	Text
Resource Type	Article
Subject	Bioengineering Pharmaceutical Science Medicine Applied Microbiology and Biotechnology Biomedical Engineering Molecular Medicine Nanoscience and Nanotechnology
Journal Impact Factor	10.6/2023
5-Year Journal Impact Factor	11.4/2023

Sl.	Authority	Responsibilities	Communication Details
1	Ministry of Education (GoI), Department of Higher Education	Sanctioning Authority	https://www.education.gov.in/ict-initiatives
2	Indian Institute of Technology Kharagpur	Host Institute of the Project: The host institute of the project is responsible for providing infrastructure support and hosting the project	https://www.iitkgp.ac.in
3	National Digital Library of India Office, Indian Institute of Technology Kharagpur	The administrative and infrastructural headquarters of the project	Dr. B. Sutradhar bsutra@ndl.gov.in
4	Project PI / Joint PI	Principal Investigator and Joint Principal Investigators of the project	Dr. B. Sutradhar bsutra@ndl.gov.in Prof. Saswat Chakrabarti will be added soon
5	Website/Portal (Helpdesk)	Queries regarding NDLI and its services	support@ndl.gov.in
6	Contents and Copyright Issues	Queries related to content curation and copyright issues	content@ndl.gov.in
7	National Digital Library of India Club (NDLI Club)	Queries related to NDLI Club formation, support, user awareness program, seminar/symposium, collaboration, social media, promotion, and outreach	clubsupport@ndl.gov.in
8	Digital Preservation Centre (DPC)	Assistance with digitizing and archiving copyright-free printed books	dpc@ndl.gov.in
9	IDR Setup or Support	Queries related to establishment and support of Institutional Digital Repository (IDR) and IDR workshops	idr@ndl.gov.in

Recent advances of fluorescent biosensors based on cyclic signal amplification technology in biomedical detection

Click chemistry-based dual nanosystem for microRNA-122 detection with single-base specificity from tumour cells

Neutrophil-mediated clinical nanodrug for treatment of residual tumor after focused ultrasound ablation

Neutrophils mediated multistage nanoparticle delivery for prompting tumor photothermal therapy

Nanoparticles mediated tumor microenvironment modulation: current advances and applications

Nanoparticle-mediated cell pyroptosis: a new therapeutic strategy for inflammatory diseases and cancer

Elastomeric microparticles for acoustic mediated bioseparations

A signal amplification assay for HSV type 1 viral DNA detection using nanoparticles and direct acoustic profiling

Bio-orthogonal click chemistry strategy for PD-L1-targeted imaging and pyroptosis-mediated chemo-immunotherapy of triple-negative breast cancer

A proof-of-concept study on bioorthogonal-based pretargeting and signal amplify radiotheranostic strategy

Similar Documents

Recent advances of fluorescent biosensors based on cyclic signal amplification technology in biomedical detection

Click chemistry-based dual nanosystem for microRNA-122 detection with single-base specificity from tumour cells

Neutrophil-mediated clinical nanodrug for treatment of residual tumor after focused ultrasound ablation

Neutrophils mediated multistage nanoparticle delivery for prompting tumor photothermal therapy

Nanoparticles mediated tumor microenvironment modulation: current advances and applications

Nanoparticle-mediated cell pyroptosis: a new therapeutic strategy for inflammatory diseases and cancer

Elastomeric microparticles for acoustic mediated bioseparations

A signal amplification assay for HSV type 1 viral DNA detection using nanoparticles and direct acoustic profiling

Bio-orthogonal click chemistry strategy for PD-L1-targeted imaging and pyroptosis-mediated chemo-immunotherapy of triple-negative breast cancer

A proof-of-concept study on bioorthogonal-based pretargeting and signal amplify radiotheranostic strategy